Jak/STAT通路:聚焦类风湿关节炎疼痛
本文综述类风湿关节炎疼痛的炎症与非炎症机制,指出Jak/STAT通路通过调控多种促炎与抗炎细胞因子参与疼痛 mediation。一项3期临床试验显示,Jak1/Jak2抑制剂在疼痛改善上显著优于TNF阻断剂,尽管两者在标准临床指标和炎症标志物变化相似。理解这些机制有助于临床优化炎症与疼痛控制。
要点
- Jak1/Jak2抑制剂在RA疼痛改善上显著优于TNF阻断剂,标准临床指标和炎症标志物变化相似。
- Jak/STAT通路直接或间接调控多种促炎与抗炎细胞因子,参与RA疼痛的炎症与非炎症机制。
- 深入理解Jak/STAT通路介导疼痛的机制有助于临床医生优化炎症与疼痛控制决策。
核心结论
- Jak1/Jak2抑制可能通过炎症与非炎症机制缓解RA疼痛,且Jak/STAT通路在多种细胞因子调控中起核心作用。
研究设计与样本
- 本文为综述,引用一项3期临床试验结果并汇总Jak/STAT通路与RA疼痛的相关文献。
主要发现
- 3期临床试验显示,接受Jak1/Jak2抑制剂治疗的RA患者疼痛改善显著优于TNF阻断剂治疗者,而两组标准临床指标和炎症标志物变化相似。
- Jak/STAT通路直接或间接调控的多种细胞因子在介导RA疼痛的多种机制中发挥重要作用。
关键数值与推荐
- 3期临床试验中,Jak1/Jak2抑制剂组疼痛改善显著大于TNF阻断剂组,两组标准临床指标和炎症标志物变化相似。
临床怎么用
- 临床医生可基于对Jak/STAT通路调控疼痛机制的理解,制定兼顾炎症与疼痛控制的治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pain is a manifestation of rheumatoid arthritis (RA) that is mediated by inflammatory and non-inflammatory mechanisms and negatively affects quality of life. Recent findings from a Phase 3 clinical trial showed that patients with RA who were treated with a Janus kinase 1 (Jak1) and Janus kinase 2 (Jak2) inhibitor achieved significantly greater improvements in pain than those treated with a tumor necrosis factor blocker; both treatments resulted in similar changes in standard clinical measures and markers of inflammation. These findings suggest that Jak1 and Jak2 inhibition may relieve pain in RA caused by inflammatory and non-inflammatory mechanisms and are consistent with the overarching involvement of the Jak-signal transducer and activator of transcription (Jak/STAT) pathway in mediating the action, expression, and regulation of a multitude of pro- and anti-inflammatory cytokines. In this review, we provide an overview of pain in RA, the underlying importance of cytokines regulated directly or indirectly by the Jak/STAT pathway, and therapeutic targeting of the Jak/STAT pathway in RA. As highlighted herein, multiple cytokines directly or indirectly regulated by the Jak/STAT pathway play important roles in mediating various mechanisms underlying pain in RA. Having a better understanding of these mechanisms may help clinicians make treatment decisions that optimize the control of inflammation and pain.
引用
- Simon LS, Taylor PC, Choy EH, et al. The Jak/STAT pathway: A focus on pain in rheumatoid arthritis. Semin Arthritis Rheum. 2020. PMID: 33412435. doi:10.1016/j.semarthrit.2020.10.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。